10x Genomics Inc - Class A

Research 10x Genomics Inc - Class A (TXG) on Bullrun: market cap USD 4.72B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerTXG
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryHealth Information Services
• CurrencyUSD
• Market capUSD 4.72B
• Financial periodFY2025
• RevenueUSD 642.82M
• Revenue growth5.2%
• Net income-USD 43.50M
• Free cash flowUSD 130.12M
• Gross margin69.1%

Valuation Snapshot

latest market cap is USD 4.72B.

About 10x Genomics Inc - Class A

10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific. The company offers Chromium platform, a single cell portfolio that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments;

Frequently asked questions

What is 10x Genomics Inc - Class A's market cap?

10x Genomics Inc - Class A's market capitalization is USD 4.72B.

What does 10x Genomics Inc - Class A do?

10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific.